Division of General Internal Medicine
Ohio State University Wexner Medical Center
3691 Ridge Mill Dr, Hilliard, OH 43026
Susan.Li@osumc.edu
(614) 688-9220
Dr. Li’s clinical and research focus is on providing primary care for cystic fibrosis (CF) patients, and understanding major limitations for their long-term mortality in the era of highly effective modulator therapy. This interest started when she first became fascinated by the disease and patients during residency training. After graduating from residency, she spent two years working at the Nationwide Children’s Adult Cystic Fibrosis Center as an adult CF provider. There, she came to more intimately learn the disease and its common complications.
With tremendous advances made within the field of CF over the past 10 years, there are now more adults than children living with CF. Her goal is to understand the new determinants of morbidity and mortality for this patient population in this new and exciting era of CF history. Her focus is on preventative medicine and extra-pulmonary disease. Clinically, this uniquely positions her to be a primary care physician with CF expertise, allowing her to provide primary care home for over 60 CF patients.
She also created the first cystic fibrosis care network in the country: a multidisciplinary network that focuses on providing comprehensive, timely, and patient-centered care for adults with cystic fibrosis. This concept is centered around primary care and the adult CF center, with a close network of specialists who are experts of common extra-pulmonary complications of CF. The ultimate goal is to develop a group of providers with CF expertise who work collaboratively and in a multidisciplinary fashion to become an adult CF patient’s medical home and care network.
From a research standpoint, her research focuses on preventative services use, transition, cardiovascular disease, cystic fibrosis related diabetes mellitus, pregnancy and pregnancy-related complications, breastfeeding, CF GI disease, dermatologic complications, among many other topics. She is also involved in multi-center studies focusing on similar outcomes.
Education and Training
The Ohio State University Wexner Medical Center and Nationwide Children's Hospital, Columbus, OH, Internal Medicine & Pediatrics Residency
University of North Carolina at Chapel Hill, Chapel Hill, NC, Doctor of Medicine
Davidson College, Davidson, NC, Bachelors of Science in Chemistry
In the Media
Large Rise in Pregnancies With Trikafta Seen at Nationwide Children’s
Select Publications
Ramsey ML, Gokun Y, Sobotka LA, Wellner MR, Porter K, Kirkby SE, Li SS, Papchristou GI, Krishna SG, Stanich PP, Hart PA, Conwell DL, Lara LF. Cystic fibrosis transmembrane conductance regulator modulator use is associated with reduced pancreatitis hospitalizations in subjects with cystic fibrosis. Am J Gastroenterol. 2021 Oct 19.
Ramsey ML, Sobotka LA, Krishna SG, Hinton A, Kirkby SE, Li SS, Meara MP, Conwell DL, Stanich PP. Cholecystectomy is safe among adults with cystic fibrosis. World Journal of Gastrointestinal Endoscopy. 2021 Sep 16; 13(9): 371-381.
Ramsey ML, Lara LL, Gariepy CE, Abu-El-Haija M, Hart PA, Hinton A, Kirkby SE, Krishna SG, Li SS, Conwell DL. National trends of hospitalizations in cystic fibrosis highlights a need for pediatric to adult transition clinics. Pancreas. 2021 May-Jun 01;50(5): 704-709.
Tumin D, Crowley EM, Li SS, Wooten W, Ren CL, Hayes D. Patterns of health insurance coverage and lung disease progression in adolescents and young adults with cystic fibrosis. Annals of American Thoracic Society. 2021 Feb;18(2): 290-299.
Li SS, Miller R, Tumin D, Stewart WCL, Tobias JD, Hayes D Jr. Lung allocation score thresholds prioritize survival after lung transplantation. Chest. 2019 July;156(1): 64-70.
Li SS, Tumin D, Krone KA, Boyer D, Kirkby SE, Mansour HM, Hayes D. Risks associated with lung transplantation in cystic fibrosis patients. Expert Rev Respir Med. 2018 Nov;12(11):893-904.
Li SS, Hayes D, Tobias J, Morgan W, Tumin D. Health insurance and use of recommended routine care in adults with cystic fibrosis. Clin Respir J. 2018 May;12(5):1981-1988.
Tumin D, Li SS, Deipanjan N, Gajarski RJ, McKee C, Tobias JD, Hayes D. Health insurance coverage among
young adult survivors of pediatric heart transplantation. J Pediatr 2017 Sept;188: 82-86.
Tumin D, Li SS, Kopp BT, Kirkby SE, Tobias JD, Morgan WJ, Hayes D. The effect of the affordable care act
dependent coverage provision on patients with cystic fibrosis. Pediatr Pulmonol. 2017 Apr;52(4):458-466.
Select Presentations
Li SS, Patel AV, Heintz J, Nance A, Rice A, Sakellaris K, Gemma S, Blanton SP, Johnson M, Stephan EM, Kirkby SE. “Pregnancy and outcomes in the era of CFTR modulators and COVID-19 pandemic.” Oral presentation, North American Cystic Fibrosis Conference. 11/3/21.
Ramsey, ML, Li SS, Kirkby SE, Heintz J, Lara LF, Conwell DL, Hart PA. “CFTR modulators and acute pancreatitis: a systematic review of the literature.” Poster presentation, North American Cystic Fibrosis Conference. 11/4/21.
Li SS. “Challenges in Use of Preventative Services in Cystic Fibrosis.” Invited speaker, Health Outcomes in Medicine Scholarship and Service Symposium. 9/10/21. Columbus, OH.
Li SS. “Emerging Challenges in Cystic Fibrosis.” Invited speaker, OSU Hospital Medicine & Med-Peds Symposium. 10/2/20. Columbus, OH.
Hayes D, Crowley EM, Li SS, Wooten W, Ren CL, Tumin D. “Patterns of health insurance coverage and lung disease progression in adolescents and young adults with cystic fibrosis.” Oral presentation, Pediatric Academic Societies. 5/4/20. Philadelphia, PA.
Li SS. “Challenges of Cystic Fibrosis Care in Modern Medicine.” Invited speaker. Internal Medicine Grand Rounds, 5/9/19. Columbus, Ohio.
Li SS, Tumin D, Stewart W, Tobias JD, Hayes D. “Stable lung transplant survival benefit at high values of the Lung Allocation Score.” Oral presentation, American Thoracic Society, 5/23/18. San Diego, California.
Li SS, Tumin D, Nemastil CJ, Krivchenia K, Hayes D. “The Ohio Medicaid expansion was not associated with increased health insurance coverage or adherence to routine care in adults with cystic fibrosis.” Poster presentation, American Thoracic Society, 5/23/17. Washington, District of Columbia.
